Related Experiment Video
Updated: Aug 9, 2025

10:26
Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster
Published on: March 12, 2018
8.1K
The Prion Basis of Progressive Neurodegenerative Disorders
1Dublin High School, 8151 Village Pkwy, Dublin, California 94568, USA.
Interdisciplinary Perspectives on Infectious Diseases
|February 24, 2023
Summary
Prion diseases are caused by infectious proteins (PrP) that misfold and aggregate in the brain. Understanding prion pathogenesis is crucial for developing therapies for neurodegenerative diseases like Alzheimer's and Parkinson's.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Prion proteins (PrP) are infectious agents lacking nucleic acids, unlike conventional pathogens.
- PrP propagates by inducing misfolding of the normal cellular prion protein (PrPC) into the disease-associated form (PrPSc).
- Accumulation of PrPSc leads to neurodegeneration and fatal spongiform encephalopathies.
Purpose of the Study:
- To review the molecular pathology of prion-based diseases.
- To highlight the relevance of prion pathogenesis principles to other neurodegenerative disorders.
- To underscore the urgent need for understanding these diseases due to increasing prevalence and lack of effective therapies.
Main Methods:
- Review of existing literature on prion diseases and related neurodegenerative conditions.
- Analysis of molecular mechanisms underlying prion propagation and neurotoxicity.
- Synthesis of insights into prion pathogenesis and its broader implications.
Main Results:
- Prion diseases result from the conformational conversion of PrPC to PrPSc, leading to protein aggregation and neuronal death.
- The molecular mechanisms of prion pathogenesis offer a framework for understanding other protein misfolding disorders.
- Despite increasing prevalence, effective treatments for prion and related neurodegenerative diseases remain elusive.
Conclusions:
- Understanding prion molecular pathology is essential for addressing fatal neurodegenerative diseases.
- The principles of prion disease are applicable to Alzheimer's, Parkinson's, and ALS, among others.
- Urgent research into the etiology and pathogenesis of these conditions is critical for public health.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
639
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
639
Amyloid Fibrils
9.7K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.7K
Disorders of the Nervous Tissue
1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Alzheimer's Disease: Overview
591
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
591
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
817
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
817

